Skip to main content
Equibles

Beneficial ownership — 13D / 13G

85,017 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
Apollo Management Holdings GP, LLC EGIO Edgio, Inc. Common Stock 13D/A 35.8% 2y
FS Capital Partners VI, LLC ARHS Arhaus, Inc. 13D/A 23.09% 2y
AstraZeneca PLC CLLS Cellectis S.A. 13D/A 22.4% 2y
Saba Capital Management, L.P. ASA ASA Gold & Precious Metals Ltd 13D/A 12.45% 2y
David Seldin BURU Nuburu, Inc. 13D/A 34% 2y
GIP II Blue Holding, L.P. HESM Hess Midstream LP 13D/A 52.2% 2y
Jay Lichter, Ph.D. (“Lichter”) JANX Janux Therapeutics, Inc. 13D/A 21.2% 2y
WHITMORE BRADFORD T SLSN Solesence, Inc. 13D/A 62.4% 2y
Hess Investments North Dakota LLC HESM Hess Midstream LP 13D/A 56% 2y
Johnson & Johnson Innovation - JJDC, Inc. NBTX Nanobiotix S.A. 13G 10.2% 2y
Engaged Capital LLC BRCC BRC Inc. 13D/A 20.6% 2y
MILLENNIUM MANAGEMENT LLC ENTA Enanta Pharmaceuticals Inc 13G 4.9% 2y
Flawless Management Inc. CISS C3is Inc. 13D 9.97% 2y
Baldo Fodera ASTR Astra Space, Inc. Class A Common Stock 13D 9.99% 2y
Cormorant Asset Management, LP KRRO Korro Bio, Inc. 13G 8.49% 2y
Steamboat Capital Partners, LLC WHLR Wheeler Real Estate Investment Trust, Inc. 13D 0.2% 2y
GLOBAL VALUE INVESTMENT CORP. FLNT Fluent, Inc. 13D 5.1% 2y
Polar Capital Holdings Plc ARQT Arcutis Biotherapeutics, Inc. 13G 7.56% 2y
Qing Cai HUANG NWGL CL Workshop Group Ltd 13D 5.7% 2y
Wing Luk CHAN NWGL CL Workshop Group Ltd 13D 5.7% 2y
Lin Li NCL Northann Corp. 13D 73.65% 2y
SIT INVESTMENT ASSOCIATES INC KTF Dws Municipal Income Trust 13D/A 11.32% 3y
SIT INVESTMENT ASSOCIATES INC NHS Neuberger High Yield Strategies Fund Inc. 13G/A 4.42% 3y
CITY OF LONDON INVESTMENT MANAGEMENT CO LTD TDF Templeton Dragon Fund Inc 13D 36.2% 3y
GAMCO INVESTORS, INC. ET AL GYRO Gyrodyne, LLC 13D/A 9.47% 3y
ORBIMED ISRAEL BIOFUND GP LIMITED PARTNERSHIP CMMB Chemomab Therapeutics Ltd. 13D/A 18.3% 3y
Praesidium Investment Management Company, LLC ZUO Zuora, Inc. 13D/A 4.9% 3y
Carvana Group, LLC ROOT Root, Inc. 13D/A 39.8% 3y
GAMCO INVESTORS, INC. ET AL CUTR Cutera, Inc. 13D/A 5.33% 3y
Paragon Technologies, Inc. OPTT Ocean Power Technologies, Inc. 13D/A 4% 3y
GAMCO INVESTORS, INC. ET AL MPTI M-tron Industries, Inc. 13D/A 8.43% 3y
FAIRFAX FINANCIAL HOLDINGS LTD/ CAN BB BLACKBERRY Ltd 13D/A 8% 3y
Advent International, L.P. CCC CCC Intelligent Solutions Holdings Inc. 13D/A 47.4% 3y
Legion Partners Asset Management, LLC OSPN OneSpan Inc. 13D/A 7.7% 3y
Politan Capital Management LP AZTA Azenta, Inc. 13D/A 7.92% 3y
Silver Lake Group, L.L.C. ROOT Root, Inc. 13D/A 0% 3y
GAMCO INVESTORS, INC. ET AL CPHC Canterbury Park Holding Corp 13D/A 7.73% 3y
Rubric Capital Management LP MREO Mereo BioPharma Group plc 13D/A 13.88% 3y
Danaos Investment Limited as Trustee of the 883 Trust DAC Danaos Corp 13D/A 47.3% 3y
Brookfield Oaktree Holdings, LLC IMPL Impel Pharmaceuticals Inc. Common Stock 13D/A 9.1% 3y
AH Bio Fund II, L.P. EQRX EQRx, Inc. Common Stock 13D/A 0% 3y
BROADWOOD PARTNERS, L.P. STAA Staar Surgical Co 13D/A 20.7% 3y
Campbell Richard D VTLE Vital Energy, Inc. 13G 6.34% 3y
H PARTNERS MANAGEMENT, LLC SIX Six Flags Entertainment Corp. 13D/A 13.65% 3y
J Arnold Wealth Management Co FAB First Trust Exchange-Traded AlphaDEX Fund 13G 11.7% 3y
RA CAPITAL MANAGEMENT, L.P. DSGN Design Therapeutics, Inc. 13G/A 0% 3y
PERCEPTIVE ADVISORS LLC CRGX CARGO Therapeutics, Inc. Common Stock 13G 8.4% 3y
Todd L. Boehly LXU Lsb Industries, Inc. 13D/A 20.6% 3y
Brian Corday DWTX Dogwood Therapeutics, Inc. 13G/A 6.84% 3y
F9 Investments, LLC (Single Member LLC with Thomas D. Sullivan Single Member) LL LL Flooring Holdings, Inc. 13D/A 8.8% 3y